Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

FDA Experts Endorse Pioneering New Gene Therapy Treatment For Blindness

Duration: 00:41s - Published: < > Embed
News video: FDA Experts Endorse Pioneering New Gene Therapy Treatment For BlindnessA new ground-breaking gene therapy from Spark Therapeutics took a huge step towards FDA approval yesterday as a panel of experts offered their support for getting the treatment into the market. The vote was 16 to 0 favoring the benefit-risk profile of the drug, providing a compelling reason for the US FDA to approve the first US vector-delivered gene therapy.

0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

Recent related news

FDA Panel Recommends Approval Of Gene Therapy To Treat Form Of Blindness

FDA Panel Recommends Approval Of Gene Therapy To Treat Form Of BlindnessA potentially groundbreaking treatment for a rare form of blindness moved one step closer to U.S....
WorldNews - Front PageAlso reported by •SeattlePI.comFuturismSeattle TimesDeseret News


New gene therapy treatment could hit $1M per patient because of additional costs

The costs of using a new class of cancer treatments include far more than the drug’s sticker...
USATODAY.com - Front Page

Spark Therapeutics surge premarket after getting FDA committee endorses its blindness treatment

Spark Therapeutics Inc. (NASDAQ:ONCE) shares surged in premarket trade after a U.S. Food and Drugs...
Proactive Investors - Business

The First Gene Therapy That Fixes Hereditary Blindness May Finally Get FDA Approval

A gene therapy treatment called Luxturna has already improved the eyesight of people suffering from a...
Futurism - Science

FDA Approves Radical New Gene-Altering Cancer Treatment

FDA Approves Radical New Gene-Altering Cancer TreatmentThe FDA has just approved the second gene-altering cancer treatment, this one for patients suffering...
Futurism - ScienceAlso reported by •Wall Street Journal


FDA approves Gilead cancer gene therapy; price set at $373,000

(Reuters) - U.S. regulators approved on Wednesday a new therapy for a type of lymphoma, which was...
Reuters - Health


You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+